Market Crash: 2 Stocks I'd Buy Without Hesitation

Shiller P/E is around 37 and Iran/Strait of Hormuz tensions have raised downside risk after a three‑year bull market; the S&P 500 is down year‑to‑date. The author recommends defensive names: Berkshire Hathaway (BRK) — trading ~15x earnings, returned +3% in the 2022 bear vs S&P -18, and is down ~4% YTD amid the CEO handoff to Greg Abel — and Coca‑Cola (KO) — up ~7% YTD, returned ~+11% in 2022, yields 2.84% and has raised its dividend for 64 consecutive years.

Analysis

Berkshire’s structural advantages — large, diversified operating cashflows plus an insurance-like float and a material cash war chest — create optionality that compounds during stress: underwriting repricing and wider credit spreads both boost near-term free cash generation and expand the universe of actionable M&A targets. The second-order effect to watch is balance-sheet timing: if credit spreads widen faster than realized losses (days–weeks), Berkshire can buy public equities and private assets with outsized implied returns; if realized losses materialize (quarters), insurance loss ratios could transiently compress earnings power.

Coca‑Cola’s concentrate/distribution economics are defensively levered to pricing, not just volumes, but the real fragility sits in the bottler network and EM FX exposures. Bottlers constrained on capex or marketing in a downturn can magnify volume declines even if shelf demand holds, and a prolonged strong USD would erode reported margins in emerging markets; both dynamics create a path where dividend resilience masks under-the-surface cash flow variability over 6–18 months.

Market positioning is key: flows into low-volatility, dividend, and value vehicles will amplify near-term bids in BRK/KO, making short-term rallies crowded and vulnerable to volatility spikes. The contrarian angle is that insurance-driven buying and concentrate-model pricing power are already partly priced — alpha is more likely from active exploitation of bottler stress, M&A execution windows, and volatility-based hedges rather than simple buy-and-hold allocations.

Key Decisions for Investors

• Long BRKB (size 1.5–3% portfolio) over 6–12 months: accumulate on small pullbacks; set target of +8–12% absolute or +6–8% relative to SPY on a >10% market drawdown. Risk control: trim to half position on a 10% absolute move against position or if insurance combined ratio deteriorates >250bps QoQ.
• Long KO + covered calls (size 1–2% portfolio) with 3–6 month calls sold 3–5% OTM to boost yield; horizon 12–18 months. Target total return 7–12% (dividends + premiums + modest upside). Stop / reassess if organic volume decline >6% YoY or FCF payout ratio breaches ~75%.
• Pair trade — long BRKB / short NVDA (equal notional delta-neutral, rebalanced monthly) for 3–9 months to capture defensive rotation while hedging growth crowding. Expect payoff if growth-led indices fall 8–15%; cap downside by limiting short NVDA size to 50–75% of long notional.
• Volatility hedge: buy 2–3% notional of 2–3 month SPX put spread (e.g., 2%/6% OTM) sized to cover tail loss of core long positions; cost small premium, asymmetric protection if geopolitical shock widens into markets over days–weeks.